Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Minocycline and Silver Dual-Loaded Polyphosphoester-Based Nanoparticles for Treatment of Resistant Pseudomonas aeruginosa.

Chen Q, Shah KN, Zhang F, Salazar AJ, Shah PN, Li R, Sacchettini JC, Wooley KL, Cannon CL.

Mol Pharm. 2019 Apr 1;16(4):1606-1619. doi: 10.1021/acs.molpharmaceut.8b01288. Epub 2019 Mar 12.

PMID:
30817887
2.

Identification of molecular signatures of cystic fibrosis disease status with plasma-based functional genomics.

Levy H, Jia S, Pan A, Zhang X, Kaldunski M, Nugent ML, Reske M, Feliciano RA, Quintero D, Renda MM, Woods KJ, Murkowski K, Johnson K, Verbsky J, Dasu T, Ideozu JE, McColley S, Quasney MW, Dahmer MK, Avner E, Farrell PM, Cannon CL, Jacob H, Simpson PM, Hessner MJ.

Physiol Genomics. 2019 Jan 1;51(1):27-41. doi: 10.1152/physiolgenomics.00109.2018. Epub 2018 Dec 12.

PMID:
30540547
3.

A novel in vitro metric predicts in vivo efficacy of inhaled silver-based antimicrobials in a murine Pseudomonas aeruginosa pneumonia model.

Shah PN, Shah KN, Smolen JA, Tagaev JA, Torrealba J, Zhou L, Zhang S, Zhang F, Wagers PO, Panzner MJ, Youngs WJ, Wooley KL, Cannon CL.

Sci Rep. 2018 Apr 23;8(1):6376. doi: 10.1038/s41598-018-24200-w.

4.

Antimicrobial Activity of Ibuprofen against Cystic Fibrosis-Associated Gram-Negative Pathogens.

Shah PN, Marshall-Batty KR, Smolen JA, Tagaev JA, Chen Q, Rodesney CA, Le HH, Gordon VD, Greenberg DE, Cannon CL.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e01574-17. doi: 10.1128/AAC.01574-17. Print 2018 Mar.

5.

Underage Drinking: A Review of Trends and Prevention Strategies.

Harding FM, Hingson RW, Klitzner M, Mosher JF, Brown J, Vincent RM, Dahl E, Cannon CL.

Am J Prev Med. 2016 Oct;51(4 Suppl 2):S148-57. doi: 10.1016/j.amepre.2016.05.020. Epub 2016 Jul 28.

6.

Clinical Practice Guidelines From the Cystic Fibrosis Foundation for Preschoolers With Cystic Fibrosis.

Lahiri T, Hempstead SE, Brady C, Cannon CL, Clark K, Condren ME, Guill MF, Guillerman RP, Leone CG, Maguiness K, Monchil L, Powers SW, Rosenfeld M, Schwarzenberg SJ, Tompkins CL, Zemanick ET, Davis SD.

Pediatrics. 2016 Apr;137(4). pii: e20151784. doi: 10.1542/peds.2015-1784. Epub 2016 Mar 23. Review.

7.

Transporting Young Passengers While Impaired: The State of the Law.

Thomas S, Kelley-Baker T, Romano E, Treffers R, Cannon CL.

Health Behav Policy Rev. 2014 Jul 1;1(4):265-277.

8.

Investigating the pharmacokinetics and biological distribution of silver-loaded polyphosphoester-based nanoparticles using (111) Ag as a radiotracer.

Aweda TA, Zhang S, Mupanomunda C, Burkemper J, Heo GS, Bandara N, Lin M, Cutler CS, Cannon CL, Youngs WJ, Wooley KL, Lapi SE.

J Labelled Comp Radiopharm. 2015 May 30;58(6):234-41. doi: 10.1002/jlcr.3289. Epub 2015 May 8.

9.

Degradable polyphosphoester-based silver-loaded nanoparticles as therapeutics for bacterial lung infections.

Zhang F, Smolen JA, Zhang S, Li R, Shah PN, Cho S, Wang H, Raymond JE, Cannon CL, Wooley KL.

Nanoscale. 2015 Feb 14;7(6):2265-70. doi: 10.1039/c4nr07103d.

PMID:
25573163
10.

The use of 111Ag as a tool for studying biological distribution of silver-based antimicrobials.

Aweda TA, Ikotun O, Mastren T, Cannon CL, Wright B, Youngs WJ, Cutler C, Guthrie J, Lapi SE.

Medchemcomm. 2013 Jun 1;4(6):1015-1017.

11.

Synthesis, characterization, and in vivo efficacy of shell cross-linked nanoparticle formulations carrying silver antimicrobials as aerosolized therapeutics.

Shah PN, Lin LY, Smolen JA, Tagaev JA, Gunsten SP, Han DS, Heo GS, Li Y, Zhang F, Zhang S, Wright BD, Panzner MJ, Youngs WJ, Brody SL, Wooley KL, Cannon CL.

ACS Nano. 2013 Jun 25;7(6):4977-87. doi: 10.1021/nn400322f. Epub 2013 Jun 4.

12.

Testing the results of municipal mixed-use zoning ordinances: a novel methodological approach.

Cannon CL, Thomas S, Treffers RD, Paschall MJ, Heumann L, Mann GW, Dunkell DO, Nauenberg S.

J Health Polit Policy Law. 2013 Aug;38(4):815-39. doi: 10.1215/03616878-2208612. Epub 2013 May 3.

PMID:
23645876
13.

Modeling the response of a biofilm to silver-based antimicrobial.

Stine AE, Nassar D, Miller JK, Clemons CB, Wilber JP, Young GW, Yun YH, Cannon CL, Leid JG, Youngs WJ, Milsted A.

Math Biosci. 2013 Jul;244(1):29-39. doi: 10.1016/j.mbs.2013.04.006. Epub 2013 Apr 27.

14.

Aerosolized antimicrobial agents based on degradable dextran nanoparticles loaded with silver carbene complexes.

Ornelas-Megiatto C, Shah PN, Wich PR, Cohen JL, Tagaev JA, Smolen JA, Wright BD, Panzner MJ, Youngs WJ, Fréchet JM, Cannon CL.

Mol Pharm. 2012 Nov 5;9(11):3012-22. doi: 10.1021/mp3004379. Epub 2012 Oct 19.

15.

Nanoparticle deposition onto biofilms.

Miller JK, Neubig R, Clemons CB, Kreider KL, Wilber JP, Young GW, Ditto AJ, Yun YH, Milsted A, Badawy HT, Panzner MJ, Youngs WJ, Cannon CL.

Ann Biomed Eng. 2013 Jan;41(1):53-67. doi: 10.1007/s10439-012-0626-0. Epub 2012 Aug 10.

16.

Synthesis, characterization, and antimicrobial activity of silver carbene complexes derived from 4,5,6,7-tetrachlorobenzimidazole against antibiotic resistant bacteria.

Wright BD, Shah PN, McDonald LJ, Shaeffer ML, Wagers PO, Panzner MJ, Smolen J, Tagaev J, Tessier CA, Cannon CL, Youngs WJ.

Dalton Trans. 2012 Jun 7;41(21):6500-6. doi: 10.1039/c2dt00055e. Epub 2012 Mar 8.

17.

Cystic fibrosis mutations for p.F508del compound heterozygotes predict sweat chloride levels and pancreatic sufficiency.

Sebro R, Levy H, Schneck K, Dimmock D, Raby BA, Cannon CL, Broeckel U, Risch NJ.

Clin Genet. 2012 Dec;82(6):546-51. doi: 10.1111/j.1399-0004.2011.01804.x. Epub 2011 Nov 29.

18.

In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria.

Leid JG, Ditto AJ, Knapp A, Shah PN, Wright BD, Blust R, Christensen L, Clemons CB, Wilber JP, Young GW, Kang AG, Panzner MJ, Cannon CL, Yun YH, Youngs WJ, Seckinger NM, Cope EK.

J Antimicrob Chemother. 2012 Jan;67(1):138-48. doi: 10.1093/jac/dkr408. Epub 2011 Oct 3.

19.

Aesthetic restoration of parotidectomy contour deformity using the supraclavicular artery island flap.

Epps MT, Cannon CL, Wright MJ, Chaffin AE, Newsome RE, Friedlander PL, Chiu ES.

Plast Reconstr Surg. 2011 May;127(5):1925-31. doi: 10.1097/PRS.0b013e31820cf40a. No abstract available.

PMID:
21532421
20.

Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis.

Beigelman A, Mikols CL, Gunsten SP, Cannon CL, Brody SL, Walter MJ.

Respir Res. 2010 Jun 30;11:90. doi: 10.1186/1465-9921-11-90.

21.

A theobromine derived silver N-heterocyclic carbene: synthesis, characterization, and antimicrobial efficacy studies on cystic fibrosis relevant pathogens.

Panzner MJ, Hindi KM, Wright BD, Taylor JB, Han DS, Youngs WJ, Cannon CL.

Dalton Trans. 2009 Sep 21;(35):7308-13. doi: 10.1039/b907726j. Epub 2009 Aug 6.

22.

Lack of correlation between pulmonary disease and cystic fibrosis transmembrane conductance regulator dysfunction in cystic fibrosis: a case report.

Levy H, Cannon CL, Asher D, García C, Cleveland RH, Pier GB, Knowles MR, Colin AA.

J Med Case Rep. 2010 Apr 26;4:117. doi: 10.1186/1752-1947-4-117.

23.
24.

Pulmonary pathology in thyroid transcription factor-1 deficiency syndrome.

Galambos C, Levy H, Cannon CL, Vargas SO, Reid LM, Cleveland R, Lindeman R, deMello DE, Wert SE, Whitsett JA, Perez-Atayde AR, Kozakewich H.

Am J Respir Crit Care Med. 2010 Aug 15;182(4):549-54. doi: 10.1164/rccm.201002-0167CR. Epub 2010 Mar 4.

25.

Synthesis and in vitro Efficacy Studies of Silver Carbene Complexes on Biosafety Level 3 Bacteria.

Panzner MJ, Deeraksa A, Smith A, Wright BD, Hindi KM, Kascatan-Nebioglu A, Torres AG, Judy BM, Hovis CE, Hilliard JK, Mallett RJ, Cope E, Estes DM, Cannon CL, Leid JG, Youngs WJ.

Eur J Inorg Chem. 2009 May 1;2009(13):1739-1745.

26.

Shell crosslinked nanoparticles carrying silver antimicrobials as therapeutics.

Li Y, Hindi K, Watts KM, Taylor JB, Zhang K, Li Z, Hunstad DA, Cannon CL, Youngs WJ, Wooley KL.

Chem Commun (Camb). 2010 Jan 7;46(1):121-3. doi: 10.1039/b916559b. Epub 2009 Nov 9.

27.

ATP7B detoxifies silver in ciliated airway epithelial cells.

Ibricevic A, Brody SL, Youngs WJ, Cannon CL.

Toxicol Appl Pharmacol. 2010 Mar 15;243(3):315-22. doi: 10.1016/j.taap.2009.11.023. Epub 2009 Dec 11.

28.

Entry of Burkholderia organisms into respiratory epithelium: CFTR, microfilament and microtubule dependence.

Taylor JB, Hogue LA, LiPuma JJ, Walter MJ, Brody SL, Cannon CL.

J Cyst Fibros. 2010 Jan;9(1):36-43. doi: 10.1016/j.jcf.2009.10.002. Epub 2009 Nov 14.

29.

The medicinal applications of imidazolium carbene-metal complexes.

Hindi KM, Panzner MJ, Tessier CA, Cannon CL, Youngs WJ.

Chem Rev. 2009 Aug;109(8):3859-84. doi: 10.1021/cr800500u. Review. No abstract available.

30.

In vitro and murine efficacy and toxicity studies of nebulized SCC1, a methylated caffeine-silver(I) complex, for treatment of pulmonary infections.

Cannon CL, Hogue LA, Vajravelu RK, Capps GH, Ibricevic A, Hindi KM, Kascatan-Nebioglu A, Walter MJ, Brody SL, Youngs WJ.

Antimicrob Agents Chemother. 2009 Aug;53(8):3285-93. doi: 10.1128/AAC.00314-09. Epub 2009 May 18.

31.

Azithromycin attenuates airway inflammation in a noninfectious mouse model of allergic asthma.

Beigelman A, Gunsten S, Mikols CL, Vidavsky I, Cannon CL, Brody SL, Walter MJ.

Chest. 2009 Aug;136(2):498-506. doi: 10.1378/chest.08-3056. Epub 2009 May 8.

PMID:
19429717
32.

The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies.

Hindi KM, Ditto AJ, Panzner MJ, Medvetz DA, Han DS, Hovis CE, Hilliard JK, Taylor JB, Yun YH, Cannon CL, Youngs WJ.

Biomaterials. 2009 Aug;30(22):3771-9. doi: 10.1016/j.biomaterials.2009.03.044. Epub 2009 Apr 23.

33.

IL-12 p80-dependent macrophage recruitment primes the host for increased survival following a lethal respiratory viral infection.

Gunsten S, Mikols CL, Grayson MH, Schwendener RA, Agapov E, Tidwell RM, Cannon CL, Brody SL, Walter MJ.

Immunology. 2009 Apr;126(4):500-13. doi: 10.1111/j.1365-2567.2008.02923.x. Epub 2008 Sep 6.

34.

Neutrophil depletion causes a fatal defect in murine pulmonary Staphylococcus aureus clearance.

Robertson CM, Perrone EE, McConnell KW, Dunne WM, Boody B, Brahmbhatt T, Diacovo MJ, Van Rooijen N, Hogue LA, Cannon CL, Buchman TG, Hotchkiss RS, Coopersmith CM.

J Surg Res. 2008 Dec;150(2):278-85. doi: 10.1016/j.jss.2008.02.009. Epub 2008 Mar 13.

35.

Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients.

Levy H, Kalish LA, Cannon CL, García KC, Gerard C, Goldmann D, Pier GB, Weiss ST, Colin AA.

Pediatr Pulmonol. 2008 May;43(5):463-71. doi: 10.1002/ppul.20794.

36.

Synthesis, stability, and antimicrobial studies of electronically tuned silver acetate N-heterocyclic carbenes.

Hindi KM, Siciliano TJ, Durmus S, Panzner MJ, Medvetz DA, Reddy DV, Hogue LA, Hovis CE, Hilliard JK, Mallet RJ, Tessier CA, Cannon CL, Youngs WJ.

J Med Chem. 2008 Mar 27;51(6):1577-83. doi: 10.1021/jm0708679. Epub 2008 Feb 21.

PMID:
18288795
37.

Airway inflammation in cystic fibrosis.

Elizur A, Cannon CL, Ferkol TW.

Chest. 2008 Feb;133(2):489-95. doi: 10.1378/chest.07-1631. Review.

PMID:
18252915
38.

Transmission of Panton-Valentine leukocidin-positive Staphylococcus aureus between patients with cystic fibrosis.

Elizur A, Orscheln RC, Ferkol TW, Dunne WM Jr, Storch GA, Cannon CL.

J Pediatr. 2007 Jul;151(1):90-2.

PMID:
17586197
39.

Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis.

Elizur A, Orscheln RC, Ferkol TW, Atkinson JJ, Dunne WM Jr, Buller RS, Armstrong JR, Mardis ER, Storch GA, Cannon CL.

Chest. 2007 Jun;131(6):1718-25. Epub 2007 Mar 30.

PMID:
17400676
40.

Synthesis from caffeine of a mixed N-heterocyclic carbene-silver acetate complex active against resistant respiratory pathogens.

Kascatan-Nebioglu A, Melaiye A, Hindi K, Durmus S, Panzner MJ, Hogue LA, Mallett RJ, Hovis CE, Coughenour M, Crosby SD, Milsted A, Ely DL, Tessier CA, Cannon CL, Youngs WJ.

J Med Chem. 2006 Nov 16;49(23):6811-8.

PMID:
17154511
41.
42.

Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.

Coleman FT, Mueschenborn S, Meluleni G, Ray C, Carey VJ, Vargas SO, Cannon CL, Ausubel FM, Pier GB.

Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1949-54. Epub 2003 Feb 10.

43.

CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation.

Schroeder TH, Lee MM, Yacono PW, Cannon CL, Gerçeker AA, Golan DE, Pier GB.

Proc Natl Acad Sci U S A. 2002 May 14;99(10):6907-12. Epub 2002 May 7.

44.

Lung infections associated with cystic fibrosis.

Lyczak JB, Cannon CL, Pier GB.

Clin Microbiol Rev. 2002 Apr;15(2):194-222. Review.

45.

Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist.

Lyczak JB, Cannon CL, Pier GB.

Microbes Infect. 2000 Jul;2(9):1051-60. Review.

PMID:
10967285
46.

Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection?

Cullen AR, Cannon CL, Mark EJ, Colin AA.

Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):641-5.

PMID:
10673211
47.

Recombinant pICln forms highly cation-selective channels when reconstituted into artificial and biological membranes.

Li C, Breton S, Morrison R, Cannon CL, Emma F, Sanchez-Olea R, Bear C, Strange K.

J Gen Physiol. 1998 Dec;112(6):727-36.

48.

Intracellular ionic strength regulates the volume sensitivity of a swelling-activated anion channel.

Cannon CL, Basavappa S, Strange K.

Am J Physiol. 1998 Aug;275(2):C416-22. doi: 10.1152/ajpcell.1998.275.2.C416.

PMID:
9688595
49.

Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes.

Dharnidharka VR, Nadeau K, Cannon CL, Harris HW, Rosen S.

Am J Kidney Dis. 1998 Apr;31(4):710-2. Review.

PMID:
9531191
50.

New epidermal model for dermal irritancy testing.

Cannon CL, Neal PJ, Southee JA, Kubilus J, Klausner M.

Toxicol In Vitro. 1994 Aug;8(4):889-91.

PMID:
20693039

Supplemental Content

Loading ...
Support Center